Tacrolimus: all 596 studies that test it
Page 1 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.
- Tacrolimus as Prophylaxis of Post-ERCP PancreatitisNot yet recruitingNCT07781722Phase 4
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional LimitationsNot yet recruitingNCT07612657Phase 3
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 WeeksNot yet recruitingNCT07519174Not applicable
- Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNot yet recruitingNCT07437534Phase 4
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisRecruitingNCT07285070Phase 2
- Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationRecruitingNCT07249346Phase 2
- Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.Not yet recruitingNCT07203664Phase 4
- Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingNCT07162896Phase 3
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Tacrolimus Eye Drops in Treatment of Vernal KeratoconjunctivitisNot yet recruitingNCT07138742Not applicable
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCTRecruitingNCT06900777Not applicable
- COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationNCT06880042Early Phase 1
- Allo HSCT for High Risk HemoglobinopathiesRecruitingNCT06872333Phase 2
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamideRecruitingNCT06828796Phase 2
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingNCT06807606Phase 2
- Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant RecipientsRecruitingNCT06751992Phase 4
- Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving TacrolimusRecruitingNCT06701825Phase 4
- Trial of Cell Based Therapy for DMDRecruitingNCT06692426Phase 1
- Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.RecruitingNCT06529536Phase 4
- Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCDNot yet recruitingNCT06405100Phase 3
- Topical Tacrolimus for Breast Cancer-related LymphedemaEnrolling by invitationNCT06306274Phase 2/3
- Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release DrugsRecruitingNCT06268769Phase 4
- Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft FailureRecruitingNCT06235892Phase 3
- Botox Versus Tacrolimus in Psoriasis VulgarisNot yet recruitingNCT06203470Phase 4
- Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeRecruitingNCT06128070Phase 2
- Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)Not yet recruitingNCT06084780Phase 2
- Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney TransplantationRecruitingNCT06057545Phase 3
- Advancing Transplantation Outcomes in ChildrenRecruitingNCT06055608Phase 2
- Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus ErythematosusRecruitingNCT05916781Phase 4
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
- Conversion of Maintenance Prograf to Envarsus in Liver Transplant RecipientsEnrolling by invitationNCT05655273Phase 4
- Uterus Transplantation to Treat InfertilityRecruitingNCT05646992Phase 2/3
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingNCT05303727Phase 2
- Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP PancreatitisRecruitingNCT05252754Phase 3
- Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release FormulationsRecruitingNCT05089604Phase 4
- Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation PatientsRecruitingNCT05001074Phase 3
- Early Use of Long-acting Tacrolimus in Lung Transplant RecipientsRecruitingNCT04469842Early Phase 1
- Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialRecruitingNCT04302870Phase 2/3
- BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)RecruitingNCT04187105Phase 2
- Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted AngiomaRecruitingNCT04056962Phase 2
- CIRTEN-Simultaneous Pancreas-Kidney Transplant RecipientsRecruitingNCT03769298Phase 2/3
- Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic ProfileRecruitingNCT03321656Phase 2/3
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsEnrolling by invitationNCT03292861Phase 2
- A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver TransplantRecruitingNCT03216447Phase 4
- Human Penile AllotransplantationRecruitingNCT02395497Phase 2/3
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingNCT01861106Phase 2
- Reduced Intensity Haploidentical BMT for High Risk Solid TumorsRecruitingNCT01804634Phase 2
- Off-the-shelf NK Cells + SCT for Myeloid MalignanciesCompletedNCT05115630Phase 2Results posted
- COVID Protection After Transplant-Immunosuppression ReductionCompletedNCT05077254Phase 2Results posted
- Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompletedNCT04788641Phase 1Results posted
- Bioequivalence Study of Tacrolimus in Healthy VolunteersCompletedNCT04725682Phase 1Results posted
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsTerminatedNCT04530487Phase 2Results posted
- Envarsus XR in Lung TransplantCompletedNCT04420195Phase 2Results posted
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationCompletedNCT04339101Phase 2Results posted
- Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaTerminatedNCT04205240Phase 2Results posted
- Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant PatientsCompletedNCT04041219Phase 4Results posted
- Envarsus XR Compared to Immediate Release TacrolimusCompletedNCT03979365Phase 4Results posted
- Envarsus in Delayed Graft Function (E-DGF)CompletedNCT03864926Phase 4Results posted
- Envarsus Neurotoxicity Burden in Liver Transplant PatientsCompletedNCT03823768Phase 4Results posted
- Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersActive, not recruitingNCT03816332Phase 1Results posted
- Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant RecipientsCompletedNCT03713645Phase 4Results posted
- 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological MalignanciesCompletedNCT03712878Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingNCT03663933Phase 2Results posted
- Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney TransplantationCompletedNCT03511560Phase 4Results posted
- Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' ExpressionCompletedNCT03480360Phase 3Results posted
- Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant RecipientsCompletedNCT03461445Phase 4Results posted
- Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant RecipientsCompletedNCT03437577Phase 1/2Results posted
- Extended Release Tacrolimus vs. Twice-Daily TacrolimusCompletedNCT03289650Phase 3Results posted
- CNS Study of Patients Switching From Tacrolimus to EnvarsusCompletedNCT03270462Phase 4Results posted
- Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant RecipientsCompletedNCT03194321Phase 4Results posted
- Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)CompletedNCT03152019Phase 2Results posted
- Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaCompletedNCT03096782Phase 2Results posted
- Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant RecipientsCompletedNCT03020589Phase 4Results posted
- Envarsus XR in African American Renal Transplant RecipientsTerminatedNCT02956005Not applicableResults posted
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UCTerminatedNCT02954159Phase 3Results posted
- Dosing Requirements of Astagraf XL® in African American Kidney Transplant RecipientsCompletedNCT02953873Phase 4Results posted
- Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)CompletedNCT02918292Phase 2Results posted
- Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best DonorCompletedNCT02880293Not applicableResults posted
- Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsTerminatedNCT02877082Phase 2Results posted
- Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant RecipientsCompletedNCT02866682Phase 4Results posted
- NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic AnemiaCompletedNCT02833805Phase 2Results posted
- Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell TransplantationActive, not recruitingNCT02782546Phase 2Results posted
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)CompletedNCT02766465Phase 2Results posted
- To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant RecipientsCompletedNCT02723591Phase 4Results posted
- TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed LymphomaCompletedNCT02652468Not applicableResults posted
- Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
- Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft MalignanciesCompletedNCT02556931Phase 2Results posted
- A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant RecipientsCompletedNCT02444143Phase 4Results posted
- Pharmacokinetic Comparison Of All FK-506 FormulationsCompletedNCT02339246Phase 3Results posted
- Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid LeukemiaCompletedNCT02328755Phase 1/2Results posted
- JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisCompletedNCT02251821Phase 2Results posted
- Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaCompletedNCT02224872Phase 2Results posted
- CCFZ533X2201 - PoC Study in de Novo Renal TransplantationCompletedNCT02217410Phase 1/2Results posted